SPY414.92-5.67 -1.35%
DIA332.96-5.20 -1.54%
IXIC14,030.38-130.97 -0.92%

Insider Trends: Insider Sales Add to 90-Day Trend at VYNE Therapeutics

05/07/2021 13:33

05:33 PM EDT, 05/07/2021 (MT Newswires) -- Perceptive Advisors Llc, 10% Owner, on May 06, 2021, sold 1,000,000 shares in VYNE Therapeutics (VYNE) for $3,670,000. Following the Form 4 filing with the SEC, Perceptive Advisors has indirect ownership of 5,773,954 shares of company stock, with a market value, based on the prior-day closing price, of $20.6 million.

During the most recent 90-day period, prior to the date of this filing, there have been 11 insider transactions reported to the SEC for VYNE Therapeutics. These transactions came from the activities of 6 different insiders that resulted in a net acquisition of 268,203 company shares. This compares with the preceding 90-day window of time where there were 9 transactions from 6 insiders which resulted in the net acquisition of 4,276,573 shares.

SEC Story Link http://www.sec.gov/Archives/edgar/data/1566044/000106299321004265/xslF345X03/form4.xml

This report does not constitute a recommendation to purchase or sell any security and the analysts are not registered investment advisors. Further analysis is recommended before undertaking any position in any security. Any risks are solely the responsibility of the buyer/seller. The authors, publishers and distributors of the MT Newswires Live Briefs service and any associates thereof accept no liability for the content or actions taken by anyone or institution utilizing this report.